Showing results (411-420 of 855) with videos related to
Sort By:
Pageof 86
Current Hematologic Malignancy Reports|January 25, 2021
A New Target for Hodgkin Lymphoma - Camidanlumab TesirineNarendranath Epperla, Mehdi HamadaniCurrent Hematologic Malignancy Reports|September 13, 2011
Rituximab maintenance versus radioimmunotherapy consolidation in follicular lymphoma: which, when, and for whom?Roswitha Forstpointner, Martin DreylingCurrent Hematologic Malignancy Reports|February 14, 2012
Genetic mechanisms of chronic myeloid leukemia blastic transformationTomasz SkorskiCurrent Hematologic Malignancy Reports|April 20, 2011
Can low-risk, early-stage patients with Hodgkin lymphoma be spared radiotherapy?Gregory M Cote, George P CanellosCurrent Hematologic Malignancy Reports|June 11, 2011
Role of tyrosine kinase inhibitors in the management of Philadelphia chromosome-positive acute lymphoblastic leukemiaMichael S Mathisen, Susan O'Brien, Deborah Thomas, et al.Current Hematologic Malignancy Reports|May 19, 2011
Primary mediastinal large B-cell lymphoma, classic Hodgkin lymphoma presenting in the mediastinum, and mediastinal gray zone lymphoma: what is the oncologist to do?Cliona Grant, Kieron Dunleavy, Franziska C Eberle, et al.Current Hematologic Malignancy Reports|September 29, 2011
Update: peripheral T-cell lymphomasKerry J SavageCurrent Hematologic Malignancy Reports|October 8, 2011
Management of refractory acute myeloid leukemia: re-induction therapy or straight to transplantation?E J Feldman, Usama GergisCurrent Hematologic Malignancy Reports|March 8, 2012
Management of chronic myeloid leukemia in childhoodMeinolf Suttorp, Louise Eckardt, Josephine Tabea Tauer, et al.Current Hematologic Malignancy Reports|October 7, 2021
A Multi-disciplinary Approach to Managing Chronic Myelogenous Leukemia Patients on Oral Anticancer Therapy at a Large Academic Medical CenterAngela Canadeo, Mary Fournogerakis, Felicia ZookPageof 86